The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insight on their sialidase activity and molecular docking.

Publication Year: 2020

DOI:
10.1016/j.jff.2020.104282

PMCID:
PMC7656998

PMID:
33199981

Journal Information

Full Title: J Funct Foods

Abbreviation: J Funct Foods

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nutrition & Dietetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors filed a Patent Cooperation Treaty (PCT, Application number: PCT/EG2018/000012, International Filing Date: 6 Dec. 2018, Publication Date: 18 Oct. 2018) with respect to the topic of sialidase activity and anti-coronavirus efficacy of RJ proteins."

Evidence found in paper:

"Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025